Lupin Gets CGT Advantage For First US Pred Forte Generic

Firm Enjoys 180-Day Exclusivity For Prednisolone Acetate Ophthalmic Suspension

 
• By Dave Wallace

Lupin will benefit from 180 days of competitive generic therapy exclusivity as it launches the first and only US rival to the $200m brand Pred Forte.

Lupin has launched the first US Pred Forte generic (Shutterstock)

More from Generics

More from Generics Bulletin